1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of TMEM158 mRNA CTD PMID:26682919 17beta-estradiol multiple interactions ISO RGD:733049 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TMEM158 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of TMEM158 mRNA CTD PMID:17404688 , PMID:20660070 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:733049 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:733049 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TMEM158 mRNA CTD PMID:21570461 2-methylcholine affects expression ISO RGD:733049 6480464 beta-methylcholine affects the expression of TMEM158 mRNA CTD PMID:21179406 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733049 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of TMEM158 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of TMEM158 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of TMEM158 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:708473 6480464 Acrylamide results in increased expression of TMEM158 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:733049 6480464 Aflatoxin B1 results in increased expression of TMEM158 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:733049 6480464 Tretinoin results in increased expression of TMEM158 mRNA CTD PMID:21934132 ammonium chloride affects expression ISO RGD:708473 6480464 Ammonium Chloride affects the expression of TMEM158 mRNA CTD PMID:16483693 atrazine decreases expression ISO RGD:733049 6480464 Atrazine results in decreased expression of TMEM158 mRNA CTD PMID:22378314 benzene-1,2,4-triol increases expression ISO RGD:733049 6480464 hydroxyhydroquinone results in increased expression of TMEM158 mRNA CTD PMID:17572062 benzo[a]pyrene affects expression ISO RGD:733049 6480464 Benzo(a)pyrene affects the expression of TMEM158 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TMEM158 mRNA CTD PMID:20127859 , PMID:27195522 benzo[a]pyrene increases expression ISO RGD:733049 6480464 Benzo(a)pyrene results in increased expression of TMEM158 mRNA CTD PMID:20064835 bisphenol A decreases expression ISO RGD:708473 6480464 bisphenol A results in decreased expression of TMEM158 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:708473 6480464 bisphenol A results in increased methylation of TMEM158 gene CTD PMID:28505145 butanal increases expression ISO RGD:733049 6480464 butyraldehyde results in increased expression of TMEM158 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TMEM158 mRNA CTD PMID:24982889 calcitriol increases expression ISO RGD:733049 6480464 Calcitriol results in increased expression of TMEM158 mRNA CTD PMID:16002434 carmustine affects response to substance ISO RGD:733049 6480464 TMEM158 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of TMEM158 mRNA CTD PMID:28472532 cobalt dichloride decreases expression ISO RGD:733049 6480464 cobaltous chloride results in decreased expression of TMEM158 mRNA CTD PMID:19320972 copper atom increases expression EXP 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:16629173 copper atom increases expression ISO RGD:708473 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:16629173 copper(0) increases expression ISO RGD:708473 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:30556269 copper(2+) increases expression EXP 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:16629173 copper(2+) increases expression ISO RGD:708473 6480464 Copper results in increased expression of TMEM158 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:733049 6480464 Asbestos, Crocidolite results in increased expression of TMEM158 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:733049 6480464 Cyclosporine results in decreased expression of TMEM158 mRNA CTD PMID:20106945 , PMID:27989131 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of TMEM158 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:733049 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of TMEM158 mRNA CTD PMID:28628672 dorsomorphin multiple interactions ISO RGD:733049 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733049 6480464 Doxorubicin results in decreased expression of TMEM158 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:733049 6480464 Doxorubicin results in increased expression of TMEM158 mRNA CTD PMID:30031762 ethanol multiple interactions ISO RGD:733049 6480464 [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TMEM158 mRNA CTD PMID:29432896 formaldehyde decreases expression ISO RGD:733049 6480464 Formaldehyde results in decreased expression of TMEM158 mRNA CTD PMID:28937961 hydrogen peroxide affects expression ISO RGD:733049 6480464 Hydrogen Peroxide affects the expression of TMEM158 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:733049 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of TMEM158 mRNA CTD PMID:28628672 lead diacetate increases expression ISO RGD:733049 6480464 lead acetate results in increased expression of TMEM158 mRNA CTD PMID:22839698 medroxyprogesterone acetate decreases expression ISO RGD:733049 6480464 Medroxyprogesterone Acetate results in decreased expression of TMEM158 mRNA CTD PMID:20843944 methylmercury chloride increases expression ISO RGD:733049 6480464 methylmercuric chloride results in increased expression of TMEM158 mRNA CTD PMID:23179753 N-nitrosodiethylamine increases expression ISO RGD:733049 6480464 Diethylnitrosamine results in increased expression of TMEM158 mRNA CTD PMID:21527772 nickel dichloride increases expression ISO RGD:733049 6480464 nickel chloride results in increased expression of TMEM158 mRNA CTD PMID:21455298 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of TMEM158 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:733049 6480464 Acetaminophen results in increased expression of TMEM158 mRNA CTD PMID:29067470 pentanal increases expression ISO RGD:733049 6480464 pentanal results in increased expression of TMEM158 mRNA CTD PMID:26079696 phenylmercury acetate decreases expression ISO RGD:733049 6480464 Phenylmercuric Acetate results in decreased expression of TMEM158 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733049 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM158 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:733049 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMEM158 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:733049 6480464 Piroxicam results in decreased expression of TMEM158 mRNA CTD PMID:21858171 progesterone multiple interactions ISO RGD:733049 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of TMEM158 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of TMEM158 mRNA CTD PMID:17404688 , PMID:20660070 progesterone decreases expression ISO RGD:733049 6480464 Progesterone results in decreased expression of TMEM158 mRNA CTD PMID:17404688 propanal increases expression ISO RGD:733049 6480464 propionaldehyde results in increased expression of TMEM158 mRNA CTD PMID:26079696 raloxifene multiple interactions ISO RGD:733049 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of TMEM158 mRNA CTD PMID:19059307 raloxifene affects expression ISO RGD:733049 6480464 Raloxifene Hydrochloride affects the expression of TMEM158 mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO RGD:733049 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:733049 6480464 Asbestos, Serpentine results in increased expression of TMEM158 mRNA CTD PMID:29523930 silicon dioxide increases expression ISO RGD:733049 6480464 Silicon Dioxide analog results in increased expression of TMEM158 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of TMEM158 mRNA CTD PMID:29203145 silicon dioxide decreases expression ISO RGD:733049 6480464 Silicon Dioxide analog results in decreased expression of TMEM158 mRNA CTD PMID:23806026 tamoxifen affects expression ISO RGD:733049 6480464 Tamoxifen affects the expression of TMEM158 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:733049 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of TMEM158 mRNA CTD PMID:19059307 temozolomide affects response to substance ISO RGD:733049 6480464 TMEM158 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide increases expression ISO RGD:733049 6480464 tert-Butylhydroperoxide results in increased expression of TMEM158 mRNA CTD PMID:15336504 thapsigargin decreases expression ISO RGD:733049 6480464 Thapsigargin results in decreased expression of TMEM158 mRNA CTD PMID:22378314 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of TMEM158 mRNA CTD PMID:23557971 trichostatin A decreases expression ISO RGD:733049 6480464 trichostatin A results in decreased expression of TMEM158 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733049 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM158 mRNA CTD PMID:27188386 tunicamycin decreases expression ISO RGD:733049 6480464 Tunicamycin results in decreased expression of TMEM158 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:733049 6480464 Urethane results in increased expression of TMEM158 mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TMEM158 mRNA CTD PMID:17963808 valproic acid affects expression ISO RGD:733049 6480464 Valproic Acid affects the expression of TMEM158 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:733049 6480464 Valproic Acid results in increased expression of TMEM158 mRNA CTD PMID:23179753 more ... 
Gene Ontology Annotations
